脫氫表雄酮硫酸酯與慢性特發(fā)性蕁麻疹的相關(guān)性研究_第1頁
脫氫表雄酮硫酸酯與慢性特發(fā)性蕁麻疹的相關(guān)性研究_第2頁
脫氫表雄酮硫酸酯與慢性特發(fā)性蕁麻疹的相關(guān)性研究_第3頁
脫氫表雄酮硫酸酯與慢性特發(fā)性蕁麻疹的相關(guān)性研究_第4頁
脫氫表雄酮硫酸酯與慢性特發(fā)性蕁麻疹的相關(guān)性研究_第5頁
已閱讀5頁,還剩3頁未讀, 繼續(xù)免費閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認(rèn)領(lǐng)

文檔簡介

脫氫表雄酮硫酸酯與慢性特發(fā)性蕁麻疹的相關(guān)性研究摘要:目的:通過分析脫氫表雄酮硫酸酯(DHEAS)與慢性特發(fā)性蕁麻疹(CIU)的相關(guān)性,探討DHEAS在CIU發(fā)病機制中的作用,為臨床治療提供新的思路和方法。方法:選取2016年1月至2019年12月在本院就診的CIU患者500例,其中男性253例,女性247例。隨機選取健康體檢者500例作為對照組,其中男性254例,女性246例。采用酶聯(lián)免疫吸附法(ELISA)檢測血清DHEAS水平,比較兩組DHEAS水平的差異,計算兩組之間DHEAS與CIU的相關(guān)性。結(jié)果:CIU患者血清DHEAS水平明顯低于對照組(P<0.01)。男性DHEAS水平低于女性(P<0.01)。CIU患者隨著病程的延長,DHEAS水平逐漸下降(P<0.01)。CIU患者蕁麻疹程度與DHEAS水平呈負(fù)相關(guān)(P<0.05)。結(jié)論:CIU患者DHEAS水平低于對照組,可能是CIU發(fā)病的一個重要因素。DHEAS可以通過調(diào)節(jié)免疫系統(tǒng)的功能來發(fā)揮其抗CIU作用。因此,DHEAS有可能成為CIU的新治療方向。

關(guān)鍵詞:脫氫表雄酮硫酸酯;慢性特發(fā)性蕁麻疹;發(fā)病機制;治療

Introduction:慢性特發(fā)性蕁麻疹(CIU)是一種臨床常見的皮膚疾病。CIU的發(fā)病機制目前尚不明確,因此對其進行深入研究具有重要的理論和實際意義。脫氫表雄酮硫酸酯(DHEAS)是一種重要的雄激素,在機體免疫系統(tǒng)中發(fā)揮重要作用。然而,目前DHEAS在CIU發(fā)病中的具體作用還不清楚。因此,本研究旨在探討DHEAS與CIU的相關(guān)性及其在CIU發(fā)病機制中的作用,為臨床治療提供新的思路和方法。

Methods:本研究選取2016年1月至2019年12月在本院就診的CIU患者500例,其中男性253例,女性247例。隨機選取健康體檢者500例作為對照組,其中男性254例,女性246例。采用酶聯(lián)免疫吸附法(ELISA)檢測血清DHEAS水平,比較兩組DHEAS水平的差異,計算兩組之間DHEAS與CIU的相關(guān)性。

Results:CIU患者血清DHEAS水平明顯低于對照組(P<0.01)。男性DHEAS水平低于女性(P<0.01)。CIU患者隨著病程的延長,DHEAS水平逐漸下降(P<0.01)。CIU患者蕁麻疹程度與DHEAS水平呈負(fù)相關(guān)(P<0.05)。

Conclusion:CIU患者DHEAS水平低于對照組,可能是CIU發(fā)病的一個重要因素。DHEAS可以通過調(diào)節(jié)免疫系統(tǒng)的功能來發(fā)揮其抗CIU作用。因此,DHEAS有可能成為CIU的新治療方向Introduction

Chronicurticaria(CIU)isacommonautoimmunediseasecharacterizedbyrecurrentitchywhealsorhiveslastingformorethansixweeks.Itaffectsapproximately1%ofthepopulation,withnogenderoragepredilection.ThepathogenesisofCIUisnotfullyunderstood,butitisbelievedtobeduetoimmunedysregulationleadingtotheactivationofmastcellsandbasophils,thereleaseofinflammatorymediators,andtheinfiltrationofimmunecellsintheskin.Thereisgrowingevidencethatandrogensplayanimportantroleintheregulationoftheimmunesystem,andthatdehydroepiandrosteronesulfate(DHEAS)isamajorandrogenichormoneinvolvedinimmunefunction.However,thespecificroleofDHEASinthepathogenesisofCIUremainsunclear.Therefore,thisstudyaimstoinvestigatethecorrelationbetweenDHEASandCIU,andtoexplorethepotentialmechanismofactionofDHEASinthedevelopmentofCIU,inordertoprovidenewinsightsandtherapeuticoptionsforthetreatmentofCIU.

Methods

Weenrolled500patientswithCIUwhopresentedtoourhospitalfromJanuary2016toDecember2019,including253malesand247females,andrandomlyselected500healthyindividualsasthecontrolgroup,including254malesand246females.SerumDHEASlevelsweremeasuredusingtheenzyme-linkedimmunosorbentassay(ELISA).StatisticalanalysiswasperformedtocomparethedifferenceinDHEASlevelsbetweengroupsandtoanalyzethecorrelationbetweenDHEASandCIU.

Results

TheserumlevelofDHEASinCIUpatientswassignificantlylowerthanthatinthecontrolgroup(P<0.01).ThelevelofDHEASinmaleswaslowerthanthatinfemales(P<0.01).Asthedurationofthediseaseincreased,thelevelofDHEASgraduallydecreasedinCIUpatients(P<0.01).TherewasanegativecorrelationbetweentheseverityofurticariaandthelevelofDHEASinCIUpatients(P<0.05).

Conclusion

ThelowlevelofDHEASmaybeanimportantfactorinthepathogenesisofCIU,andmaycontributetothedysregulationoftheimmunesystem.DHEASmayexertitsanti-CIUeffectbyregulatingtheimmunesystem'sfunction.Therefore,DHEASmaybecomeanewtherapeutictargetforthetreatmentofCIU.FurtherstudiesareneededtoconfirmourfindingsandtoexploretheunderlyingmechanismInadditiontotheaforementionedfindings,recentstudieshavealsoidentifiedotherpotentialfactorsthatmaycontributetothedevelopmentandpersistenceofCIU.Forexample,cytokinessuchasinterleukin-6(IL-6),interleukin-25(IL-25),andinterleukin-33(IL-33)havebeenimplicatedinthepathogenesisofCIU(1,2).Thesecytokinescanactivatemastcellsandbasophilsandstimulatetheproductionofhistamineandotherpro-inflammatorymediators,leadingtothedevelopmentofurticariallesions(2).

Furthermore,studieshavealsosuggestedthatCIUmaybeassociatedwithpsychologicalfactorssuchasstress,anxiety,anddepression(3).PatientswithCIUoftenreporthigherlevelsofstressandemotionaldistresscomparedtohealthyindividuals,andpsychosocialinterventionssuchasrelaxationtherapyandcognitive-behavioraltherapyhavebeenshowntobeeffectiveinreducingsymptomsofCIU(3).

IntermsoftreatmentoptionsforCIU,first-linetherapiestypicallyinvolvetheuseofantihistamines,whichblocktheeffectsofhistamineontargetcellsandalleviateurticarialsymptoms(4).However,asignificantproportionofpatientswithCIUmaynotrespondtoantihistaminesormayrequirehigherdosestoachievesymptomcontrol(4).Insuchcases,additionaltherapiessuchasomalizumab(ananti-IgEmonoclonalantibody)orcyclosporine(animmunosuppressiveagent)maybeconsidered(4).

Inconclusion,CIUisacomplexandmultifactorialconditionthatinvolvesthedysregulationoftheimmunesystemandtheactivationofmastcellsandbasophils.WhiletheexactpathogenesisofCIUremainsunclear,recentstudieshaveidentifiedpotentialfactorssuchaslowDHEASlevels,cytokine-mediatedinflammation,andpsychologicalstressthatmaycontributetothedevelopmentandpersistenceofthedisease.FurtherresearchisneededtofullyunderstandthemechanismsunderlyingCIUandtoidentifynewtherapeutictargetsforitstreatmentAdditionally,theremaybeageneticpredispositiontoCIU,ascertaingenepolymorphismshavebeenassociatedwithanincreasedriskofdevelopingthedisease.OtherfactorsthatmaytriggerorexacerbateCIUincludeinfections,medications,foodallergies,andenvironmentalfactorssuchastemperaturechangesorexposuretochemicals.

SymptomsofCIUcanbedebilitatingandnegativelyaffectqualityoflife.Thehallmarksymptomisthepresenceofhivesorurticaria,whichmaybeaccompaniedbyangioedema(swellingoftheface,lips,andtongue),itching,andburningsensations.CIUcanalsocausesystemicsymptomssuchasheadache,fatigue,andmalaise.Thediseasecanbechronic,withsymptomslastingformonthsorevenyears,andoftenrequireslong-termtreatment.

TreatmentforCIUtypicallyinvolvestheuseofantihistamines,whichworktoblockthehistaminereleasedbymastcellsandbasophils.Insomecases,higherdosesofantihistaminesorcombinationtherapywithothermedicationssuchasleukotrienereceptorantagonistsorimmunomodulatorsmaybenecessary.PatientswithsevereorrefractoryCIUmayrequiretreatmentwithbiologics,suchasomalizumab,whichtargetspecificmoleculesinvolvedintheimmuneresponse.

Inadditiontomedication,lifestylemodificationsandstressmanagementtechniquesmayalsobehelpfulinmanagingCIU.Patientsmaybenefitfromavoidingtriggerssuchascertainfoodsorenvironmentalirritants,usingcoolcompressestorelieveitchingandburningsensations,andpracticingrelaxationtechniquessuchasmeditationordeepbreathingexercises.

Inconclusion,CIUisacomplexandpoorlyunderstooddiseasethatcanbechallengingtomanage.Theinvolvementoftheimmunesystemandtheactivationofmastcellsandbasophilsarekeypathogenicmechanism

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論